SHINE
SHINE, based in Wisconsin, USA, is advancing fusion technology to deliver reliable, high-quality medical isotopes. Its proprietary process powers the commercial production of isotopes used to diagnose and treat cancer and heart disease. SHINE has also applied fusion to neutron imaging and is pioneering nuclear waste recycling. With a commercially driven model, SHINE is making fusion practical today—transforming healthcare, energy, and technology while building a more resilient, sustainable supply of critical radioisotopes for the future.
